- Home
- MBINM vs IMNM Comparison
MBINM vs IMNM Comparison
Compare MBINM & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBINM
- IMNM
- Stock Information
- Founded
- MBINM N/A
- IMNM 2006
- Country
- MBINM United States
- IMNM United States
- Employees
- MBINM 618
- IMNM N/A
- Industry
- MBINM Major Banks
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- MBINM Finance
- IMNM Health Care
- Exchange
- MBINM Nasdaq
- IMNM Nasdaq
- Market Cap
- MBINM N/A
- IMNM 747.7M
- IPO Year
- MBINM N/A
- IMNM 2020
- Fundamental
- Price
- MBINM $25.72
- IMNM $11.89
- Analyst Decision
- MBINM
- IMNM Strong Buy
- Analyst Count
- MBINM 0
- IMNM 4
- Target Price
- MBINM N/A
- IMNM $28.75
- AVG Volume (30 Days)
- MBINM N/A
- IMNM 873.3K
- Earning Date
- MBINM N/A
- IMNM 11-07-2024
- Dividend Yield
- MBINM N/A
- IMNM N/A
- EPS Growth
- MBINM N/A
- IMNM N/A
- EPS
- MBINM N/A
- IMNM N/A
- Revenue
- MBINM N/A
- IMNM $10,784,000.00
- Revenue This Year
- MBINM N/A
- IMNM N/A
- Revenue Next Year
- MBINM N/A
- IMNM N/A
- P/E Ratio
- MBINM N/A
- IMNM N/A
- Revenue Growth
- MBINM N/A
- IMNM 62.73
- 52 Week Low
- MBINM N/A
- IMNM $6.93
- 52 Week High
- MBINM N/A
- IMNM $30.96
- Technical
- Relative Strength Index (RSI)
- MBINM 49.85
- IMNM 33.67
- Support Level
- MBINM $25.56
- IMNM $11.92
- Resistance Level
- MBINM $26.00
- IMNM $13.40
- Average True Range (ATR)
- MBINM 0.32
- IMNM 0.80
- MACD
- MBINM -0.04
- IMNM -0.26
- Stochastic Oscillator
- MBINM 31.45
- IMNM 3.16
About MBINM Merchants Bancorp Depositary Shares Each Representing a 1/40th Interest in a Share of 8.25% Fixed-Rate Reset Series D Non-Cumulative Perpetual Preferred Stock
Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and Banking segment that provides a wide range of financial products and services to consumers and businesses, including commercial and other consumer loan products.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.